Jessica Winn focuses her practice in the areas of executive compensation, equity compensation and employee benefits, with an emphasis on mergers and acquisitions and initial public offerings. Her experience includes parachute payment analysis.
Cooley advised M33 Growth, a venture and growth-stage investment firm, on a series of strategic investments in:
Operix (formerly IFS Core), a provider of software solutions for specialty contractors that allow for more efficient management of field operations personnel and processes through seamless integrations with core accounting platforms.
PerformLine, a provider of a cloud-based, multichannel sales and marketing compliance platform for the banking, mortgage, insurance and financial services industries to monitor enterprise communication channels for regulatory and brand compliance and improve reporting and issue remediation workflows.
Leading2Lean, a provider of a cloud-based digital workflow platform for discrete manufacturers that enables factories to implement more efficient production and maintenance processes.
Yapi, a provider of a communication and patient engagement platform for dental offices that streamlines front office and marketing workflows, automates appointment reminders and digitizes paper-based forms such as patient consents.
Cooley advised Nutrafol, a leading provider of hair wellness products, on its agreement to sell a majority stake in the company to Unilever. Partner Kevin Cooper led the Cooley team advising Nutrafol on the transaction, and partner Stephane Levy has acted as longtime corporate counsel to the company. Nutrafol is backed by Unilever Ventures and consumer-focused private equity firm L Catterton.
Thirty Madison to Combine With Nurx to Create One Virtual Specialty Care Platform
February 12, 2022
Cooley advised Thirty Madison, a specialty healthcare company for people living with chronic conditions, on its agreement to merge with female-focused digital healthcare company Nurx. Partners Ian Nussbaum and Adam Dinow led the Cooley team advising Nurx.
Baylis Medical Agrees to Sell to Boston Scientific for $1.75 Billion
October 21, 2021
Cooley advised Baylis Medical on its agreement to sell its cardiology business to Boston Scientific for an upfront payment of $1.75 billion. Michael McGrail, Michal Berkner, William Corcoran, Jacqueline Grise and Joshua Friedman led the Cooley team advising Baylis Medical.
Battery Ventures portfolio company CAMBRIO sold to Sandvik
October 18, 2021
Cooley advised CAMBRIO, a leading computer-aided design/computer-aided manufacturing (CAD/CAM) software developer for manufacturing industries, in its sale by Battery Ventures to Sandvik AB, a Sweden-based multinational engineering company. Cooley advised Battery Ventures on the buy and build transactions to create CAMBRIO, including Battery’s initial buyout of SIGMATEK Systems in 2018, as well as add-on transactions acquiring companies with complementary technologies, Cimatron and GibbsCAM. With the sale transaction, the combined and rebranded company CAMBRIO was integrated into Sandvik’s design and planning automation division.